semaglutide ileus legal team in kentucky digestive blockage Zepbound Lawsuit [2026] kentucky semaglutide gastroparesis legal team

In February 2026, the FDA publicly announced its intent to take action targeting mass-marketed, non-FDA-approved compounded GLP1 products, emphasizing that promotional claims implying equivalence to FDAapproved drugs can trigger enforcement risk

Importantly, both before the initiation of this therapy and during the course of treatment, the patient was not taking any other medications

PlexusDx ensures reliable access to quality-tested compounded medications regardless of future regulatory shifts

Semaglutide does all these things in a more potent and sustained way than the body's own GLP-1 because it resists enzymatic breakdown

Amycretin is an investigational medication in both pill and injection form that may be as effective as some GLP-1s for weight loss

These effects tend to lessen over time as the body adjusts